Oral Candida and Entembacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy

Oral swabs of 73 HIV-1 infected men (32 under conditions of antimycotic treatment (43,8%)) and 58 controls were cultured for Candida species and Enterobacteriaceae. In Group A without antimycotics, yeasts were isolated from 35/41 swabs (85,4%) (range 2× 10⁶−4 × 10⁶ cfu/ml). In Group B with antimycotics, yeasts were cultured from 27/32 swabs (84,4%) (4×10¹−1 × 10⁶cfu/ml). Oral Enterobacteriaceae (o.e.) were grown from 22% of the swabs of both Group A (2× 10¹−2 × 10⁶cfu/ml) and Group B(4×10⁶−1,6× 10⁶cfu/ml). Growth of o.e. and yeasts (2 × 10⁶−4 × 10⁶cfu/ml). Correlation between yeasts and o. e. were isolated in 14% (2×10¹−6,4 × 10⁶cfu/ml). Correlation between yeasts species to local and systemic treatment deserves further investigations.